Clinical trial
A Prospective Observational Study of Biologic Treatment and Outcomes in Patients With Severe Asthma (BREATH)
NCT07567690 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study of Biologic Treatment and Outcomes in Patients With Severe Asthma (BREATH)
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 19, 2025
- Completion date
- December 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asthma, biologics, immunogenicity